BsAb	Bispecific Antibody
CAR T-cell therapy	Chimeric Antigen Receptor T-Cell Therapy
HDCT/ASCT	High-Dose Chemotherapy/Autologous Stem Cell Transplantation
CRS	Cytokine Release Syndrome
ICANS	Immune Effector Cell-Associated Neurotoxicity Syndrome
CR	Complete Remission
VGPR	Very Good Partial Response
PR	Partial Response
SD	Stable Disease
PD	Progressive Disease
PFS	Progression-Free Survival
OS	Overall Survival
CI	Confidence Interval
HR	Hazard Ratio